| pubmed-article:21293390 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21293390 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:21293390 | lifeskim:mentions | umls-concept:C0020538 | lld:lifeskim |
| pubmed-article:21293390 | lifeskim:mentions | umls-concept:C1801960 | lld:lifeskim |
| pubmed-article:21293390 | lifeskim:mentions | umls-concept:C0597357 | lld:lifeskim |
| pubmed-article:21293390 | lifeskim:mentions | umls-concept:C0216784 | lld:lifeskim |
| pubmed-article:21293390 | lifeskim:mentions | umls-concept:C1412113 | lld:lifeskim |
| pubmed-article:21293390 | lifeskim:mentions | umls-concept:C1306673 | lld:lifeskim |
| pubmed-article:21293390 | lifeskim:mentions | umls-concept:C0205374 | lld:lifeskim |
| pubmed-article:21293390 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:21293390 | pubmed:dateCreated | 2011-4-18 | lld:pubmed |
| pubmed-article:21293390 | pubmed:abstractText | The present study examined the inhibitory action of temporary treatment with an angiotensin type 1 (AT(1)) receptor blocker (ARB) on vascular remodeling using hypertensive mice with overexpression of the human renin (hRN) and angiotensinogen (hANG) genes. | lld:pubmed |
| pubmed-article:21293390 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21293390 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21293390 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21293390 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21293390 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21293390 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21293390 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21293390 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21293390 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21293390 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21293390 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21293390 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21293390 | pubmed:month | May | lld:pubmed |
| pubmed-article:21293390 | pubmed:issn | 1941-7225 | lld:pubmed |
| pubmed-article:21293390 | pubmed:author | pubmed-author:HigakiJitsuoJ | lld:pubmed |
| pubmed-article:21293390 | pubmed:author | pubmed-author:IwaiMasaruM | lld:pubmed |
| pubmed-article:21293390 | pubmed:author | pubmed-author:HoriuchiMasat... | lld:pubmed |
| pubmed-article:21293390 | pubmed:author | pubmed-author:MogiMasakiM | lld:pubmed |
| pubmed-article:21293390 | pubmed:author | pubmed-author:OkayamaHideki... | lld:pubmed |
| pubmed-article:21293390 | pubmed:author | pubmed-author:InabaShinjiS | lld:pubmed |
| pubmed-article:21293390 | pubmed:author | pubmed-author:KannoHarumiH | lld:pubmed |
| pubmed-article:21293390 | pubmed:author | pubmed-author:SenbaIzumiI | lld:pubmed |
| pubmed-article:21293390 | pubmed:author | pubmed-author:FurunoMegumiM | lld:pubmed |
| pubmed-article:21293390 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21293390 | pubmed:volume | 24 | lld:pubmed |
| pubmed-article:21293390 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21293390 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21293390 | pubmed:pagination | 550-6 | lld:pubmed |
| pubmed-article:21293390 | pubmed:meshHeading | pubmed-meshheading:21293390... | lld:pubmed |
| pubmed-article:21293390 | pubmed:meshHeading | pubmed-meshheading:21293390... | lld:pubmed |
| pubmed-article:21293390 | pubmed:meshHeading | pubmed-meshheading:21293390... | lld:pubmed |
| pubmed-article:21293390 | pubmed:meshHeading | pubmed-meshheading:21293390... | lld:pubmed |
| pubmed-article:21293390 | pubmed:meshHeading | pubmed-meshheading:21293390... | lld:pubmed |
| pubmed-article:21293390 | pubmed:meshHeading | pubmed-meshheading:21293390... | lld:pubmed |
| pubmed-article:21293390 | pubmed:meshHeading | pubmed-meshheading:21293390... | lld:pubmed |
| pubmed-article:21293390 | pubmed:meshHeading | pubmed-meshheading:21293390... | lld:pubmed |
| pubmed-article:21293390 | pubmed:meshHeading | pubmed-meshheading:21293390... | lld:pubmed |
| pubmed-article:21293390 | pubmed:meshHeading | pubmed-meshheading:21293390... | lld:pubmed |
| pubmed-article:21293390 | pubmed:meshHeading | pubmed-meshheading:21293390... | lld:pubmed |
| pubmed-article:21293390 | pubmed:meshHeading | pubmed-meshheading:21293390... | lld:pubmed |
| pubmed-article:21293390 | pubmed:meshHeading | pubmed-meshheading:21293390... | lld:pubmed |
| pubmed-article:21293390 | pubmed:meshHeading | pubmed-meshheading:21293390... | lld:pubmed |
| pubmed-article:21293390 | pubmed:meshHeading | pubmed-meshheading:21293390... | lld:pubmed |
| pubmed-article:21293390 | pubmed:meshHeading | pubmed-meshheading:21293390... | lld:pubmed |
| pubmed-article:21293390 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21293390 | pubmed:articleTitle | Temporary treatment with AT1 receptor blocker, valsartan, from early stage of hypertension prevented vascular remodeling. | lld:pubmed |
| pubmed-article:21293390 | pubmed:affiliation | Department of Molecular Cardiovascular Biology and Pharmacology, Ehime University Graduate School of Medicine, Japan. | lld:pubmed |
| pubmed-article:21293390 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21293390 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
